These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36291568)

  • 1. Antipsychotic Drug Fluphenazine against Human Cancer Cells.
    Duarte D; Vale N
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant Drug Sertraline against Human Cancer Cells.
    Duarte D; Vale N
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro anticancer activity of fluphenazine, perphenazine and prochlorperazine. A review.
    Otręba M; Kośmider L
    J Appl Toxicol; 2021 Jan; 41(1):82-94. PubMed ID: 32852120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
    Yıldız M; Osman E
    Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds--implications for pharmacokinetics of selected substrates.
    El Ela AA; Härtter S; Schmitt U; Hiemke C; Spahn-Langguth H; Langguth P
    J Pharm Pharmacol; 2004 Aug; 56(8):967-75. PubMed ID: 15285840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs.
    Duarte D; Cardoso A; Vale N
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuroleptic drug fluphenazine induces a significant UVA-mediated cytotoxic effect on three human cancer cell lines through apoptosis.
    Menilli L; García-Argáez AN; Dalla Via L; Miolo G
    Photochem Photobiol Sci; 2019 Sep; 18(9):2232-2239. PubMed ID: 30860541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased lipid peroxidation, apoptosis and selective cytotoxicity in colon cancer cell line LoVo and its doxorubicin-resistant subline LoVo/Dx in the presence of newly synthesized phenothiazine derivatives.
    Środa-Pomianek K; Michalak K; Świątek P; Poła A; Palko-Łabuz A; Wesołowska O
    Biomed Pharmacother; 2018 Oct; 106():624-636. PubMed ID: 29990852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluphenazine (oral) versus placebo for schizophrenia.
    Matar HE; Almerie MQ; Sampson S
    Schizophr Bull; 2013 Nov; 39(6):1187-8. PubMed ID: 24072807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluphenazine (oral) versus placebo for schizophrenia.
    Matar HE; Almerie MQ; Sampson S
    Cochrane Database Syst Rev; 2013 Jul; 7(7):CD006352. PubMed ID: 23861067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral fluphenazine versus placebo for schizophrenia.
    Matar HE; Almerie MQ
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006352. PubMed ID: 17253589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
    Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depot fluphenazine for schizophrenia.
    Adams CE; Eisenbruch M
    Cochrane Database Syst Rev; 2000; (2):CD000307. PubMed ID: 10796340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate.
    Viala A; Ba B; Durand A; Gouezo F; Hou N; Jørgensen A
    Psychopharmacology (Berl); 1988; 94(3):293-7. PubMed ID: 2895936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depot fluphenazine decanoate and enanthate for schizophrenia.
    David A; Adams CE; Eisenbruch M; Quraishi S; Rathbone J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD000307. PubMed ID: 15674872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing fluphenazine as an autophagy modulator for treating liver cancer.
    Su C; Cheng CY; Rong Z; Yang JC; Li ZM; Yao JY; Liu A; Yang L; Zhao MG
    Heliyon; 2023 Dec; 9(12):e22605. PubMed ID: 38107270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological properties of fluphenazine-mustard, an irreversible calmodulin antagonist.
    Hait WN; Glazer L; Kaiser C; Cross J; Kennedy KA
    Mol Pharmacol; 1987 Sep; 32(3):404-9. PubMed ID: 3670276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring plasma levels of fluphenazine during chronic therapy with fluphenazine decanoate.
    Miller RS; Peterson GM; McLean S; Westhead TT; Gillies P
    J Clin Pharm Ther; 1995 Apr; 20(2):55-62. PubMed ID: 7650075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anti-calmodulin drugs on the growth and sensitivity of C6 rat glioma cells to bleomycin.
    Hait WN; Gesmonde JF; Lazo JS
    Anticancer Res; 1994; 14(5A):1711-21. PubMed ID: 7531409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.